Not applicableUnknownNCT03429517What this trial is testingLevels of Triglycerides and HDL-C in ACS PatientsWho this might be right forDyslipidemia Associated With Acute Coronary Syndrome Assiut University 120
Not applicableStudy completedNCT07445542What this trial is testingEfficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With HypercholesterolemiaWho this might be right forHypercholesterolemia JW Pharmaceutical 6,927
Testing effectiveness (Phase 2)Study completedNCT00689442What this trial is testingSafety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) LevelsWho this might be right forDyslipidemia Akros Pharma Inc. 105
Post-approval studies (Phase 4)Study completedNCT02984982What this trial is testingEvaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With HypercholesterolemiaWho this might be right forHypercholesterolemiaAcute Coronary Syndrome Sanofi 206
Large-scale testing (Phase 3)Study completedNCT00240305What this trial is testingInvestigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic SyndromeWho this might be right forMetabolic SyndromeDyslipidemia AstraZeneca 15
Testing effectiveness (Phase 2)Study completedNCT03815812What this trial is testingMultiple Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Chinese Patients With HypercholesterolemiaWho this might be right forHypercholesterolemia Innovent Biologics (Suzhou) Co. Ltd. 60
Post-approval studies (Phase 4)Study completedNCT00185107What this trial is testingEffect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High CholesterolWho this might be right forHypercholesterolemia Daiichi Sankyo 45
Post-approval studies (Phase 4)UnknownNCT02035644What this trial is testingStudy on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study)Who this might be right forType 2 DiabetesDyslipidemia Shanghai Jiao Tong University School of Medicine 360
Large-scale testing (Phase 3)UnknownNCT04161001What this trial is testingClinical Trail to Evaluate the Efficacy and Safety of DWJ1451Who this might be right forHypertension, Dyslipidemia Daewoong Pharmaceutical Co. LTD. 237
Post-approval studies (Phase 4)UnknownNCT01564875What this trial is testingEfficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With HyperlipidemiaWho this might be right forChronic Kidney DiseaseHyperlipidemia Hanmi Pharmaceutical Company Limited 122
Large-scale testing (Phase 3)Active Not RecruitingNCT04951219What this trial is testingEvaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)Who this might be right forNon-Alcoholic Fatty Liver Disease Madrigal Pharmaceuticals, Inc. 810
Not applicableActive Not RecruitingNCT04579367What this trial is testingTreatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed DyslipidemiaWho this might be right forHypercholesterolemiaMixed Dyslipidemia Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 5,000
Post-approval studies (Phase 4)Study completedNCT00442325What this trial is testingBenefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol TargetsWho this might be right forCoronary ArteriosclerosisDiabetes Mellitus, Type 2Cerebrovascular Accident+2 more Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 595
Large-scale testing (Phase 3)Study completedNCT00362323What this trial is testingFenofibrate and Metformin Fixed Combination vs Metformin - FAME METFOWho this might be right forDyslipidemia/Glucose Metabolism Disorder Solvay Pharmaceuticals 482
Large-scale testing (Phase 3)Study completedNCT00269217What this trial is testingLipid Efficacy Study (0524B-022)(COMPLETED)Who this might be right forPrimary HypercholesterolemiaMixed Hyperlipidemia Merck Sharp & Dohme LLC 1,400
Not applicableNot Yet RecruitingNCT07606118What this trial is testingAn Observational Study to Evaluate Treatment Patterns in High, Very High and Extreme Cardiovascular Risk Patients With Hypercholesterolemia, Including Familial HypercholesterolemiaWho this might be right forHypercholesterolaemiaFamilial HypercholesterolaemiaCVD Risk Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) 2,500
Post-approval studies (Phase 4)WithdrawnNCT00738985What this trial is testingEfficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk FactorsWho this might be right forCardiovascular DiseasesHyperlipidemia Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Post-approval studies (Phase 4)Ended earlyNCT00651378What this trial is testingSwitching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)Who this might be right forHypercholesterolemiaAtherosclerosisCoronary Artery Disease Organon and Co 87
Testing effectiveness (Phase 2)Study completedNCT03110848What this trial is testingEffects of Atorvastatin in Graves' Orbitopathy (GO)Who this might be right forThyroid Associated OphthalmopathyHypercholesterolemia University of Pisa 88
Not applicableStudy completedNCT06866509What this trial is testingTo Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia PatientsWho this might be right forDyslipidemia Daewoong Pharmaceutical Co. LTD. 3,000